Fungal infection characteristic in type 2 diabetic mellitus: Narrative review

Author(s): Avina Alawya, Victa Ryza Catartika
DOI: 10.30867/gikes.v5i3A.1790

Abstract

Background: Individuals diagnosed with type 2 diabetes mellitus demonstrate a weakened immune system compared to those in a state of excellent health, rendering them more vulnerable to viral, bacterial, and fungal infections.

Objective: This study aimed to examine the characteristics of fungal infections in individuals diagnosed with type 2 diabetes mellitus (DM).

Methods: This study is a narrative review that conducted a comprehensive search of literature worldwide using the e-library PubMed. The journals that fulfilled the inclusion criteria were further examined and interpreted in the form of narratives.

Fungal infections include genitourinary fungal infections, oral fungal infections, invasive fungal diseases, and fungal infections in diabetic foot ulcers. Some studies have found that the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors may be associated with fungal infections. In addition, studies have discussed the types of fungal infections in diabetic patients, as well as their association with SGLT2 inhibitor use. In addition, one study examined the association between IL-23R polymorphisms and fungal infections.

Conclusion: Patients with type 2 diabetes are prone to a range of diseases including fungal infections. In addition to immunocompromised conditions, patients with type 2 DM are susceptible to fungal infections due to factors such as the administration of SGLT2 inhibitor medications and the influence of the IL-23R gene polymorphism.

 

Keywords

Characteristic of fungal infection, diabetes mellitus type 2, fungal infection, infection

Full Text:

PDF

References

Aamir, A. H., Raja, U. Y., Qureshi, F. M., Asghar, A., Mahar, S. A., Ahmed, I., Ghaffar, T., Zafar, J., Hasan, M. I., Riaz, A., Raza, S. A., Khosa, I. A., Khan, J., & Baqar, J. Bin. (2022). Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial. BMC Endocrine Disorders, 22(1), 1–10. https://doi.org/10.1186/s12902-022-01213-1

Adimadhyam, S., Schumock, G. T., Calip, G. S., Smith Marsh, D. E., Layden, B. T., & Lee, T. A. (2019). Increased risk of mycotic infections associated with sodium–glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis. British Journal of Clinical Pharmacology, 85(1), 160–168. https://doi.org/10.1111/bcp.13782

Akash, M. S. H., Rehman, K., Fiayyaz, F., Sabir, S., & Khurshid, M. (2020). Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies. Archives of Microbiology, 202(5), 953–965. https://doi.org/10.1007/s00203-020-01818-x

Al-Badri, A. S., Ali, E. N., & Ali Ajah, H. (2022). Effect of IL-23 receptor gene polymorphism (rs1884444) on the prevalence of oral fungal infection in patients with type 2 diabetes mellitus: a case-control study in Iraqi Patients. Archives of Razi Institute, 77(5), 1527–1534. https://doi.org/10.22092/ARI.2022.357754.2096

American Diabetes Association. (2018). Standards of medical care in diabetes—2018 abridged for primary care providers. Clinical Diabetes, 36(1), 14–37. https://doi.org/10.2337/cd17-0119

Berbudi, A., Rahmadika, N., Tjahjadi, A. I., & Ruslami, R. (2019). Type 2 diabetes and its impact on the immune system. Current Diabetes Reviews, 16(5), 442–449. https://doi.org/10.2174/1573399815666191024085838

Chávez-Reyes, J., Escárcega-González, C. E., Chavira-Suárez, E., León-Buitimea, A., Vázquez-León, P., Morones-Ramírez, J. R., Villalón, C. M., Quintanar-Stephano, A., & Marichal-Cancino, B. A. (2021). Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Frontiers in Public Health, 9(February), 1–18. https://doi.org/10.3389/fpubh.2021.559595

Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 1–34. https://doi.org/10.3390/ijms21176275

Hsu, T. J., & Lee, C. H. (2023). Implantation mycoses and invasive fungal infections with cutaneous involvement in tropical taiwan: an 11-year retrospective study of a medical center. Journal of Fungi, 9(3). https://doi.org/10.3390/jof9030322

Kandregula, S., Behura, A., Behera, C. R., Pattnaik, D., Mishra, A., Panda, B., & Mohanty, S. (2022). A clinical significance of fungal infections in diabetic foot ulcers. Cureus, 14(7). https://doi.org/10.7759/cureus.26872

Laakso, M. (2016). Epidemiology of type 2 diabetes. type 2 diabetes: Principles and Practice, Second Edition, 10, 1–12. https://doi.org/10.3109/9780849379581-4

Lao, M., Li, C., Li, J., Chen, D., Ding, M., & Gong, Y. (2020). Opportunistic invasive fungal disease in patients with type 2 diabetes mellitus from Southern China: Clinical features and associated factors. Journal of Diabetes Investigation, 11(3), 731–744. https://doi.org/10.1111/jdi.13183

Li, M., Yue, C., Jin, G., Guo, H., Ma, H., Wang, G., Huang, S., Wu, F., & Zhao, X. (2019). Rs1884444 variant in IL23R gene is associated with a decreased risk in esophageal cancer in Chinese population. Molecular Carcinogenesis, 58(10), 1822–1831. https://doi.org/10.1002/mc.23069

Li, Y., Fang, W., Jiang, W., Hagen, F., Liu, J., Zhang, L., Hong, N., Zhu, Y., Xu, X., Lei, X., Deng, D., Xu, J., Liao, W., Boekhout, T., Chen, M., & Pan, W. (2017). Cryptococcosis in patients with diabetes mellitus II in mainland China: 1993-2015. Mycoses, 60(11), 706–713. https://doi.org/10.1111/myc.12645

Man, A., Ciurea, C. N., Pasaroiu, D., Savin, A. I., Toma, F., Sular, F., Santacroce, L., & Mare, A. (2017). New perspectives on the nutritional factors influencing growth rate of Candida albicans in diabetics. An in vitro study. Memorias Do Instituto Oswaldo Cruz, 112(9), 587–592. https://doi.org/10.1590/0074-02760170098

Musyoki, V. M., Mutai, W., Ngugi, N., Otieno, F., & Masika, M. M. (2022). Speciation and antifungal susceptibility of Candida isolates from diabetic foot ulcer patients in a tertiary hospital in Kenya. Pan African Medical Journal, 41. https://doi.org/10.11604/pamj.2022.41.34.30815

Petersmann, A., Müller-Wieland, D., Müller, U. A., Landgraf, R., Nauck, M., Freckmann, G., Heinemann, L., & Schleicher, E. (2019). Definition, classification and diagnosis of diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes, 127(Suppl 1), S1–S7. https://doi.org/10.1055/a-1018-9078

Petrovic, S. M., Radunovic, M., Barac, M., Pficer, J. K., Pavlica, D., Arsenijevic, V. A., & Pucar, A. (2019). Subgingival areas as potential reservoirs of different candida spp in type 2 diabetes patients and healthy subjects. PLoS ONE, 14(1), 1–14. https://doi.org/10.1371/journal.pone.0210527

Rodrigues, C. F., Rodrigues, M. E., & Henriques, M. (2019). Candida sp. Infections in patients with diabetes mellitus. Journal of Clinical Medicine, 8(1), 1–40. https://doi.org/10.3390/jcm8010076

Saud, B., Bajgain, P., Paudel, G., Shrestha, V., Bajracharya, D., Adhikari, S., Dhungana, G., & Awasthi, M. S. (2020). Fungal infection among diabetic and nondiabetic individuals in Nepal. Interdisciplinary Perspectives on Infectious Diseases, 2020. https://doi.org/10.1155/2020/7949868

Sweatt,S.K, Gower, B.A, Chieh, A.Y, Liu, Y, Li, L. (2016). 乳鼠心肌提取 HHS public access. physiology & behavior, 176(1), 139–148. https://doi.org/10.7326/M18-3136.Sodium-glucose

Webber, S. (2013). International diabetes federation in diabetes research and clinical practice (Vol. 102, Issue 2). https://doi.org/10.1016/j.diabres.2013.10.013

Yokoyama, H., Nagao, A., Watanabe, S., & Honjo, J. (2019). Incidence and risk of vaginal candidiasis associated with sodium–glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes. Journal of Diabetes Investigation, 10(2), 439–445. https://doi.org/10.1111/jdi.12912

DOI: http://dx.doi.org/10.30867/gikes.v5i3A.1790

Refbacks

  • There are currently no refbacks.